CLOS
BNTX icon

Compagnie Lombard Odier SCmA’s BioNTech BNTX Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$334K Sell
3,560
-650
-15% -$61.2K ﹤0.01% 243
2026
Q1 		$368K Buy
4,210
+750
+22% +$77.1K ﹤0.01% 215
2025
Q4 		$331K Sell
3,460
-130
-4% -$13.1K ﹤0.01% 223
2025
Q3 		$351K Hold
3,590
– – ﹤0.01% 216
2025
Q2 		$385K Hold
3,590
– – 0.01% 197
2025
Q1 		$320K Hold
3,590
– – ﹤0.01% 226
2024
Q4 		$404K Hold
3,590
– – 0.01% 196
2024
Q3 		$424K Sell
3,590
-650
-15% -$59.8K 0.01% 189
2024
Q2 		$342K Sell
4,240
-9,000
-68% -$823K 0.01% 202
2024
Q1 		$1.23M Sell
13,240
-15,780
-54% -$1.51M 0.02% 150
2023
Q4 		$3.05M Sell
29,020
-1,300
-4% -$131K 0.06% 128
2023
Q3 		$3.21M Sell
30,320
-4,360
-13% -$482K 0.07% 115
2023
Q2 		$3.75M Sell
34,680
-3,344
-9% -$376K 0.1% 88
2023
Q1 		$4.69M Sell
38,024
-83
-0.2% -$11.4K 0.12% 90
2022
Q4 		$5.82M Buy
38,107
+5,860
+18% +$902K 0.16% 85
2022
Q3 		$4.38M Sell
32,247
-39,800
-55% -$6.08M 0.13% 80
2022
Q2 		$10.7M Buy
72,047
+1,500
+2% +$229K 0.27% 61
2022
Q1 		$12M Buy
70,547
+7,248
+11% +$1.22M 0.25% 64
2021
Q4 		$15.4M Buy
63,299
+18,600
+42% +$5.09M 0.31% 57
2021
Q3 		$12.4M Buy
44,699
+20,234
+83% +$6.43M 0.27% 65
2021
Q2 		$5.47M Buy
24,465
+22,155
+959% +$4.18M 0.12% 83
2021
Q1 		$250K Buy
+2,310
New +$245K 0.01% 361

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Compagnie Lombard Odier SCmA's BNTX Position: Q2 2026 in Review

Compagnie Lombard Odier SCmA reduced its BioNTech (BNTX) stake by 15% in Q2 2026, selling an estimated $61.2K and leaving 3,560 shares worth $334K. The position accounts for ﹤0.01% of the portfolio, ranked #243.

Compagnie Lombard Odier SCmA first reported a position in BNTX in Q1 2021 and has held it in 22 quarters since. The position peaked at $15.4M in Q4 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Compagnie Lombard Odier SCmA held 3,560 shares of BioNTech worth $334K as of Q2 2026.
  • Compagnie Lombard Odier SCmA sold 650 BioNTech shares in Q2 2026, an estimated $61.2K.
  • BioNTech made up ﹤0.01% of Compagnie Lombard Odier SCmA's portfolio in Q2 2026, its #243 holding.
  • Compagnie Lombard Odier SCmA first reported a position in BioNTech in Q1 2021 and has held it in 22 quarters since.
  • Compagnie Lombard Odier SCmA's BioNTech position peaked at $15.4M in Q4 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2026, filed 29 Jul 2026.